0001562180-23-002040.txt : 20230301
0001562180-23-002040.hdr.sgml : 20230301
20230301160640
ACCESSION NUMBER: 0001562180-23-002040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230227
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burke Steven Keith
CENTRAL INDEX KEY: 0001619834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 23693475
MAIL ADDRESS:
STREET 1: 82 WILLIS ROAD
CITY: SUDBURY
STATE: MA
ZIP: 01776
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-02-27
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001619834
Burke Steven Keith
C/O AKEBIA THERAPEUTICS, INC
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, Chief Medical Officer
Common Stock
2023-02-27
4
S
false
7539.00
0.8132
D
608177.00
D
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
/s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke
2023-03-01